Summary
Since a previous review by Hurwitz was published in 1977 a large number of reports on drug interactions with antacids have appeared, few of which are of clinical relevance.
Tetracyclines form insoluble complex molecules by metal ion chelation with various antacids; tetracycline absorption may be decreased by more than 90% by this interaction. Of the new class of quinolone antibiotics, the absorption of Ciprofloxacine and ofloxacine is reduced by 50 to 90% in the presence of aluminium- and magnesium hydroxide-containing antacids.
In contrast to early work showing inhibition of the absorption of β-adrenergic blocking drugs by antacids, subsequent studies did not confirm a reduction in the bioavailability of either atenolol or propranolol during antacid treatment; indeed, they showed an increase in the plasma concentrations of metoprolol when the drug was coadministered with an antacid. The bioavailability of Captopril was significantly reduced in the presence of an antacid, and lower plasma concentrations of this angiotensin-converting enzyme inhibitor were accompanied by a reduction of its effect on the systolic blood pressure of the patients. The absorption of the cardiac glycosides digoxin and digitoxin is not inhibited by antacids to a significant degree, although earlier studies had shown a positive effect when the dissolution of the glycoside preparations was relatively poor.
Antacids reduce the bioavailability of the H2-receptor antagonists Cimetidine and ranitidine only when high antacid doses are used and when the drugs are administered simultaneously. The bioavailability of famotidine was not significantly altered by a potent antacid preparation, although a trend towards reduced absorption was observed. Iron absorption is significantly decreased in the presence of sodium bicarbonate and calcium carbonate, but is nearly complete when coadministered with aluminium-magnesium hydroxide.
Nonsteroidal anti-inflammatory drugs such as naproxen, tenoxicam, ketoprofen, ibuprofen and piroxicam are not affected in their absorption by antacid treatment. Theophylline bioavailability is unchanged when the drug is given together with antacids, although its rate of absorption may be altered, leading to a reduction or an increase in the time of the occurrence of peak plasma drug concentrations.
Similar content being viewed by others
References
Albert A. Avidity of terramycin and aurcomycin for metallic calions. Nature 172: 210. 1953
Albin H. Demotes-Mainard F. Vincon G. Bedjaoui A. Bcgaud B. Effect of two antacids on the bioavailability of paracetamol. European Journal of Clinical Pharmacology 29: 251–25.1. 1985
Allen MD. Greenblatt DJ. Harmatz JS. Smith TW. Effect of magnesium-hydroxide and kaolin-pectin on absorption of digoxin from tablets and capsules. Journal of Clinical Pharmacology 21: 26–30. 1981
Andcrsson KE. Brail L. Dencker C, Kamme C, Lanncr E. Inhibition of tetracycline absorption by zinc. European Journal of Clinical Pharmacology 10: 59–62. 1976
Arnold LA. Spurbeck GH. Shelver WH. Henderson WM. Effect of an antacid on gastrointestinal absorption of theophylline. American Journal of Hospital Pharmacology 36: 1059–1062. 1979
Barr WH. Adir J. Ciarrettson L. Decrease of tetracycline absorption in man by sodium bicarbonate. Clinical Pharmacology and Therapeutics 12: 779–784. 1971
Bessman SP. Doorenbos NJ. Chelation (editorial). Annals of Internal Medicine 47: 1036–1041. 1957
Bodcmar G. Norlander B. Walen A. Diminished absorption of Cimetidine caused by antacids. Letter. Lancet 1: 444–445. 1979
Bonelli J. Hruby K. Maagomctschnigg D. Hitzcnbcrgcr G. Kaik G. The bioavailability of β-acetyldigoxin alone and combined with aluminum hydroxide and magnesium hydroxide (Alucol). International Journal of Clinical Pharmacology 15: 337–339. 1977
Brazier JL. Tamisier JN. Ambert D. Bannier A. Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate. European Journal of Clinical Pharmacology 19: 305–307. 1981
Brown DD. Juhl RP. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. New England Journal of Medicine 295: 1034–1037. 1976
Burland WL. Darkin DW. Mills MW. Effects of antacids on absorption of Cimetidine. Lancet 2: 965, 1976
Cooke J. Smith JA. Absence of interaction of digoxin with antacids under clinical conditions. Letter. British Medical Journal 2: 1166–1167. 1978
Darzentas LJ. Stewart RB. Curry SH. Yost RL. Effect of antacid on bioavailability of a sustained-release theophylline preparation. Drug Intelligence and Clinical Pharmacy 17: 555–557. 1983
Day RO. Lam S. Pauli P. Wade D. Effect of food and various antacids on the absorption of tenoxicam. British Journal of Clinical Pharmacology 24: 323–328. 1987
Dobbs JH. Shoutakis VA. Acchiardo SR. Dobbs BR. Effects of aluminum hydroxide on the absorption of propranolol. Current Therapeutic Research 21: 887–892. 1977
Feldman S. Carlstedt BC. Effect of antacid on absorption of enteric-coated aspirin. Journal of the American Medical Association 227: 660–661. 1974
Fleming LW, Moreland TA. Stewart WK. Scott AC. Ciprofloxacin and antacids. Lancet 2: 294. 1986
Garty M. Hurwitz A. Effect of Cimetidine and antacids on gastrointestinal absorption of tetracycline. Clinical Pharmacology and Therapeutics 28: 203–207. 1980
Gontarz N. Small RE. Comstock TJ. Stalker DJ. Johnson SM. et al. Effect of antacid suspension on the pharmacokinetics of ibuprofen. Clinical Pharmacology 6: 413–416. 1987
Gugler R. Brand M. Somogyi G. Impaired Cimetidine absorption due to antacids and metoclopramide. European Journal of Clinical Pharmacology 20: 225–228. 1981
Harcourt RS. Hamburger M. The effect of magnesium sulfate in lowering tetracycline blood levels. Journal of Laboratory and Clinical Medicine 50: 464–468. 1987
Hobbs DC. Twomey TM. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. Journal of Clinical Pharmacology 19: 270–281. 1979
Hofften G. Borner K. Glalzel PD. Koeppe P. Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. European Journal of Clinical Microbiology 3: 345. 1985
Hofften G. Lode H. Wiley R. Glatzel TD. Sievers D. et al. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Reviews of Infectious Diseases 10 (Suppl. 1): 138–139, 1988
Hong CY. Hu SC. Lin SJ. Chiang BN. Lack of influence of aluminum hydroxide on the bioavailability and beta-adrenoceptor blocking activity of propranolol. International Journal of Clinical Pharmacology, Therapy and Toxicology 23: 244–246, 1985
Hurwitz A. Antacid therapy and drug kinetics. Clinical Pharmacokinetics 2: 269–280. 1977
Ismail FA. Khalafallah N. Khalil SA. Adsorption of ketoprofen and bumadizone calcium on aluminum containing antacids and its effects on ketoprofen bioavailability in man. International Journal of Pharmacy 34: 189–196, 1987
Kakcmi K. Sezaki H. Ogata H. Nadai T. Effect of CA2+ on the absorption of tetracycline from the small intestine (2). Chemical Pharmaceutical Bulletin 16: 2206–2212. 1968
Khalil SAH. The uptake of digoxin and digitoxin by some antacids. Journal of Pharmacy and Pharmacology 26: 961–967, 1974
Kuhlmann J. Plasmaspiegel und renale Elimination von Digitoxin bei Langzeittherapie mit Aluminium-Magncsium-Hy-droxid-Gel. Deutsche Medizinische Wochenschrift 109: 59–61. 1984
Levy G. Lampman T. Kamath BL. Decreased serum salicylate concentrations in patients with rheumatic fever treated with antacid. New England Journal of Medicine 293: 323–325. 1975
Lin JH. Chremos AN. Kanovsky SM. Schwartz S, Yeh KC. et al. Effects of antacids and food on absorption of famotidine. British Journal of Pharmacology 24: 551–553. 1987
Lode H. Drug interactions with quinolones. Reviews of Infectious Diseases 10 (Suppl. 1): 132–135. 1988
Mäntylä R, Männisto PT. Vuorela A. Sundberg S, Otloila P. Impairment of Captopril bioavailability by concomitant food and antacid intake. International Journal of Clinical Pharmacology, Therapy and Toxicology 33: 626–629, 1984
Marecek N. Lücker PW. Penth B. Altmayer P. Wetzelsberger K. Zur Pharmakokinetik von Tiaprofensäure und zur Frage der Interaktion mit ASS und Aluminiumhydroxid. Arzneimittel-forschung 31: 116–120. 1981
McElnay JC. Harron DWG. D’Arcy PF. Eagle MRG. Interaction of digoxin with activated dimethicone and other antacid constituents. Experientia 35: 94. 1979
Mihaly GW, Marino AT, Webster LK. Jones DB. Louis WJ. et al. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine. British Medical Journal 285: 998–999. 1982
Myhre Kl, Walstad RA. The influence of antacid on the absorption of two different sustained-release formulations of theophylline. British Journal of Clinical Pharmacology 15: 683–687. 1983
Ncuvonen PJ. Interactions with the absorption of tetracyclines. Drugs 11: 45–54. 1976
Neuvonen PJ. Gothoni G. Hackman R. Bjorksten K. Interference of iron with the absorption of tetracyclines in man. British Medical Journal 4: 532–534. 1970
O’Neil-Cutting SM. Crosby WH. The effect of antacids on the absorption of simultaneously ingested iron. Journal of the American Medical Association 255: 1468–1470, 1986
Poiger H. Schlatter CH. Interaction of cations and chelators with the intestinal absorption of tetracycline. Naunyn-Schmiede-berg’s Archives of Pharmacology 306: 89–92. 1979
Preheim LC. Cuevas TA, Roccaforte JS. Mellencamp MA. Bitner MJ. Ciprofloxacin and antacids. Letter. Lancet 2: 48. 1986
Ratcliffe NT. Smith JT. Effects of magnesium on the activity of 4-quinolme antibacterial agents. Journal of Pharmacy and Pharmacology 35: 61. 1983
Reed RC. Schwartz HJ. Lack of influence of an intensive antacid regimen on theophylline bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 12: 315–331. 1984
Regardh CG. Lundborg P. Persson BA. The effect of antacid, meloclopramide, and propantheline on the bioavailability of metoprolol and atenolol. Biopharmaceutics and Drug Disposition 2: 79–87. 1981
Rocher I. Henry JF. Flouvat B. The effect of antacid and aspirin on the bioavailability of isofezolac in man. International Journal of Clinical Pharmacology. Therapy and Toxicology 22: 464–469. 1984
Russell WL, Lopez LM. Normann SA. Doering PL. Guild RT. Effect of antacids on predicted steady-state Cimetidine concentrations. Digestive Diseases and Sciences 29: 385–389. 1984
Segré EJ, Sevelius H. Varady J. Effects of antacids on naproxen absorption. New England Journal of Medicine 291: 582–583, 1974
Shelly DW, Doering PL. Russell WL. Guild RT. Lopez LM. et al. Effect of concomitant antacid administration on plasma Cimetidine concentrations during repetitive dosing. Drug Intelligence and Clinical Pharmacy 20: 792–795. 1986
Schach von Wittenau M. Some pharmacokinetic aspects of doxy-cycline metabolism in man. Chemotherapy 13 (Suppl): 41–50. 1968
Steinberg WM. Lewis JH. Katz DM. Antacids inhibit absorption of Cimetidine. New England Journal of Medicine 307: 400–404. 1982
Stoel U, Newman EC. Asleson GL, Frank CW. Potentiometric and spectral investigations of anhydrotetracycline and its metalion complexes. Journal of Pharmaceutical Sciences 65: 1794–1799. 1976
Waisbren BA. Hueckel JS. Reduced absorption of aureomycin caused by aluminum hydroxide gel (Amphojel). Proceedings of the Society of Experimental Biology and Medicine 73: 73–74. 1950
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gugler, R., Allgayer, H. Effects of Antacids on the Clinical Pharmacokinetics of Drugs. Clin Pharmacokinet 18, 210–219 (1990). https://doi.org/10.2165/00003088-199018030-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199018030-00003